Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of Helicobacter pylori-Associated Gastric Cancer: Structure-Based In Silico Screening of Natural Compounds
Abstract
:1. Introduction
2. Methodology
2.1. Protein Preparation
2.2. Virtual Screening
2.3. Molecular Docking
2.4. In Silico Physicochemical, Pharmacokinetics, Drug-Likeness and ADMET Prediction
2.5. Molecular Dynamics Simulation
3. Results and Discussion
4. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Sample Availability
References
- Rawla, P.; Barsouk, A. Epidemiology of gastric cancer: Global trends, risk factors and prevention. Prz. Gastroenterol. 2019, 14, 26–38. [Google Scholar] [CrossRef] [PubMed]
- Warren, J.R.; Marshall, B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1983, 1, 1273–1275. [Google Scholar] [PubMed]
- Charitos, I.A.; D’Agostino, D.; Topi, S.; Bottalico, L. 40 Years of Helicobacter pylori: A Revolution in Biomedical Thought. Gastroenterol. Insights 2021, 12, 111–135. [Google Scholar] [CrossRef]
- Rothenbacher, D.; Brenner, H. Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: Recent developments and future implications. Microbes Infect. 2003, 5, 693–703. [Google Scholar] [CrossRef]
- Hackett, R.J.; Preston, S.L. H. pylori infection, part I: Clinical burden and diagnosis. Trends Urol. Men’s Health 2021, 12, 13–19. [Google Scholar] [CrossRef]
- Odenbreit, S.; Puls, J.; Sedlmaier, B.; Gerland, E.; Fischer, W.; Haas, R. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 2000, 287, 1497–1500. [Google Scholar] [CrossRef]
- Murata-Kamiya, N.; Kikuchi, K.; Hayashi, T.; Higashi, H.; Hatakeyama, M. Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 2010, 7, 399–411. [Google Scholar] [CrossRef] [Green Version]
- Handa, O.; Naito, Y.; Yoshikawa, T. CagA protein of Helicobacter pylori: A hijacker of gastric epithelial cell signaling. Biochem. Pharmacol. 2007, 73, 1697–1702. [Google Scholar] [CrossRef]
- Saadat, I.; Higashi, H.; Obuse, C.; Umeda, M.; Murata-Kamiya, N.; Saito, Y.; Lu, H.; Ohnishi, N.; Azuma, T.; Suzuki, A.; et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 2007, 447, 330–333. [Google Scholar] [CrossRef]
- Hatakeyama, M. Structure and function of Helicobacter pylori CagA, the first-identified bacterial protein involved in human cancer. Proc. Jpn. Academy Ser. B Phys. Biol. Sci. 2017, 93, 196–219. [Google Scholar] [CrossRef] [Green Version]
- Sabe, V.T.; Ntombela, T.; Jhamba, L.A.; Maguire, G.E.; Govender, T.; Naicker, T.; Kruger, H.G. Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review. Eur. J. Med. Chem. 2021, 224, 113705. [Google Scholar] [CrossRef] [PubMed]
- Usha, T.; Shanmugarajan, D.; Goyal, A.K.; Kumar, C.S.; Middha, S.K. Recent Updates on Computer-aided Drug Discovery: Time for a Paradigm Shift. Curr. Top Med. Chem. 2017, 17, 3296–3307. [Google Scholar] [CrossRef] [PubMed]
- Newman, D.J.; Cragg, G.M. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. J. Nat. Prod. 2020, 83, 770–803. [Google Scholar] [CrossRef] [PubMed]
- Wali, A.F.; Majid, S.; Rasool, S.; Shehada, S.B.; Abdulkareem, S.K.; Firdous, A.; Beigh, S.; Shakeel, S.; Mushtaq, S.; Akbar, I.; et al. Natural products against cancer: Review on phytochemicals from marine sources in preventing cancer. Saudi Pharm. J. 2019, 27, 767–777. [Google Scholar] [CrossRef] [PubMed]
- Yuan, H.; Ma, Q.; Ye, L.; Piao, G. The Traditional Medicine and Modern Medicine from Natural Products. Molecules 2016, 21, 559. [Google Scholar] [CrossRef] [Green Version]
- Bonifacio, B.V.; dos Santos Ramos, M.A.; da Silva, P.B.; Bauab, T.M. Antimicrobial activity of natural products against Helicobacter pylori: A review. Ann. Clin. Microbiol. Antimicrob. 2014, 13, 54. [Google Scholar] [CrossRef] [Green Version]
- Hayashi, T.; Senda, M.; Morohashi, H.; Higashi, H.; Horio, M.; Kashiba, Y.; Nagase, L.; Sasaya, D.; Shimizu, T.; Venugopalan, N.; et al. Tertiary structure-function analysis reveals the pathogenic signaling potentiation mechanism of Helicobacter pylori oncogenic effector CagA. Cell Host Microbe 2012, 12, 20–33. [Google Scholar] [CrossRef] [Green Version]
- Morris, G.M.; Huey, R.; Lindstrom, W.; Sanner, M.F.; Belew, R.K.; Goodsell, D.S.; Olson, A.J. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. 2009, 30, 2785–2791. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Pires, D.E.; Blundell, T.L.; Ascher, D.B. pkCSM: Predicting Small-Molecule Pharmacokinetic and Toxicity Properties Using Graph-Based Signatures. J. Med. Chem. 2015, 58, 4066–4072. [Google Scholar] [CrossRef]
- Sander, T.; Freyss, J.; von Korff, M.; Rufener, C. DataWarrior: An open-source program for chemistry aware data visualization and analysis. J. Chem. Inf. Model 2015, 55, 460–473. [Google Scholar] [CrossRef]
- Hansson, T.; Oostenbrink, C.; van Gunsteren, W. Molecular dynamics simulations. Curr. Opin. Struct. Biol. 2002, 12, 190–196. [Google Scholar] [CrossRef]
- Anwer, K.; Sonani, R.; Madamwar, D.; Singh, P.; Khan, F.; Bisetty, K.; Ahmad, F.; Hassan, M.I. Role of N-terminal residues on folding and stability of C-phycoerythrin: Simulation and urea-induced denaturation studies. J. Biomol. Struct. Dyn. 2015, 33, 121–133. [Google Scholar] [CrossRef] [PubMed]
- Stephens, D.E.; Khan, F.I.; Singh, P.; Bisetty, K.; Singh, S.; Permaul, K. Creation of thermostable and alkaline stable xylanase variants by DNA shuffling. J. Biotechnol. 2014, 187, 139–146. [Google Scholar] [CrossRef] [PubMed]
- Yan-Jing, W.; Faez Iqbal, K.; Qin, X.; Dong-Qing, W. Recent Studies of Mitochondrial SLC25: Integration of Experimental and Computational Approaches. Curr. Protein Pept. Sci. 2017, 18, 1–16. [Google Scholar] [CrossRef]
- Van Der Spoel, D.; Lindahl, E.; Hess, B.; Groenhof, G.; Mark, A.E.; Berendsen, H.J. GROMACS: Fast, flexible, and free. J. Comput. Chem. 2005, 26, 1701–1718. [Google Scholar] [CrossRef]
- Pol-Fachin, L.; Fernandes, C.L.; Verli, H. GROMOS96 43a1 performance on the characterization of glycoprotein conformational ensembles through molecular dynamics simulations. Carbohydr. Res. 2009, 344, 491–500. [Google Scholar] [CrossRef]
- Schuttelkopf, A.W.; van Aalten, D.M. PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr. D Biol. Crystallogr. 2004, 60, 1355–1363. [Google Scholar] [CrossRef] [Green Version]
- Humphrey, W.; Dalke, A.; Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 1996, 14, 33–38. [Google Scholar] [CrossRef]
- Yong, X.; Tang, B.; Li, B.S.; Xie, R.; Hu, C.J.; Luo, G.; Qin, Y.; Dong, H.; Yang, S.M. Helicobacter pylori virulence factor CagA promotes tumorigenesis of gastric cancer via multiple signaling pathways. Cell Commun. Signal 2015, 13, 30. [Google Scholar] [CrossRef] [Green Version]
- Ansari, S.; Yamaoka, Y. Helicobacter pylori Virulence Factor Cytotoxin-Associated Gene A (CagA)-Mediated Gastric Pathogenicity. Int. J. Mol. Sci. 2020, 21, 7430. [Google Scholar] [CrossRef]
- Vo, V.A.; Lee, J.W.; Shin, S.Y.; Kwon, J.H.; Lee, H.J.; Kim, S.S.; Kwon, Y.S.; Chun, W. Methyl p-Hydroxycinnamate Suppresses Lipopolysaccharide-Induced Inflammatory Responses through Akt Phosphorylation in RAW264.7 Cells. Biomol. Ther. 2014, 22, 10–16. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kubo, I.; Nihei, K.; Tsujimoto, K. Methyl p-coumarate, a melanin formation inhibitor in B16 mouse melanoma cells. Bioorganic Med. Chem. 2004, 12, 5349–5354. [Google Scholar] [CrossRef] [PubMed]
- Barry, D.P.; Asim, M.; Leiman, D.A.; de Sablet, T.; Singh, K.; Casero, R.A., Jr.; Chaturvedi, R.; Wilson, K.T. Difluoromethylornithine is a novel inhibitor of Helicobacter pylori growth, CagA translocation, and interleukin-8 induction. PLoS ONE 2011, 6, e17510. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schmitz, S.; Schrautemeier, B.; Bohme, H. Evidence from directed mutagenesis that positively charged amino acids are necessary for interaction of nitrogenase with the [2Fe-2S] heterocyst ferredoxin (FdxH) from the cyanobacterium Anabaena sp., PCC7120. Mol. Gen. Genet. 1993, 240, 455–460. [Google Scholar] [CrossRef]
- Robertson, D.S. Investigations of the bipartite structure of the white-albino maize mutants. Mol. Gen. Genet. 1971, 112, 93–103. [Google Scholar] [CrossRef]
- Kuzmanic, A.; Zagrovic, B. Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors. Biophys. J. 2010, 98, 861–871. [Google Scholar] [CrossRef] [Green Version]
- Mazola, Y.; Guirola, O.; Palomares, S.; Chinea, G.; Menendez, C.; Hernandez, L.; Musacchio, A. A comparative molecular dynamics study of thermophilic and mesophilic beta-fructosidase enzymes. J. Mol. Model 2015, 21, 2772. [Google Scholar] [CrossRef]
- Hubbard, R.E.; Kamran Haider, M. Hydrogen Bonds in Proteins: Role and Strength. In eLS; John Wiley & Sons, Ltd.: Hoboken, NJ, USA, 2001. [Google Scholar] [CrossRef]
- Maisuradze, G.G.; Liwo, A.; Scheraga, H.A. Principal component analysis for protein folding dynamics. J. Mol. Biol. 2009, 385, 312–329. [Google Scholar] [CrossRef] [Green Version]
- Tiana, G.; Simona, F.; De Mori, G.M.; Broglia, R.A.; Colombo, G. Understanding the determinants of stability and folding of small globular proteins from their energetics. Protein Sci. A Publ. Protein Soc. 2004, 13, 113–124. [Google Scholar] [CrossRef]
Descriptor/Properties | Value | ||
---|---|---|---|
ZINC153731 | ZINC69482055 | ZINC164387 | |
Molecular Weight | 178.187 | 358.434 | 267.275 |
Monoisotopic Mass | 178.062995 | 358.178025 | 267.032953 |
Rotatable Bonds | 2 | 1 | 0 |
Acceptors | 3 | 5 | 2 |
Donors | 1 | 1 | 1 |
cLogP | 1.5561 | 3.0513 | 4.6289 |
cLogS | −1.831 | −3.355 | −4.672 |
Total Surface Area | 76.271 | 264.17 | 177.93 |
Relative PSA | 0.24733 | 0.23553 | 0.1627 |
Polar Surface Area | 46.53 | 80.67 | 37.33 |
Drug-likeness | −4.3625 | 1.4711 | −7.4682 |
Mutagenic | none | none | high |
Tumorigenic | none | none | none |
Irritant | none | none | none |
Drug Score | 0.4833717 | 0.7209172 | 0.1100568 |
Property | Model Name | Predicted Value | Unit | |||
---|---|---|---|---|---|---|
ZINC164387 | ZINC69482055 | ZINC153731 | ||||
Absorption | Water solubility | −5.452 | −3.955 | −1.944 | log mol/L | |
Caco2 permeability | 1.527 | 1.292 | 1.189 | log Papp in 10−6 cm/s | ||
Intestinal absorption | 88.982 | 98.872 | 95.107 | % Absorbed | ||
Skin permeability | −2.544 | −4.244 | −2.503 | log Kp | ||
P-glycoprotein (P-gp) substrate | No | Yes | No | |||
P-gp I inhibitor | No | No | No | |||
P-gp II inhibitor | No | No | No | |||
Distribution | VDss (human) | 0.504 | 0.004 | −0.15 | log L/kg | |
Fraction unbound | 0.018 | 0.267 | 0.396 | Fu | ||
permeability | BBB | 0.588 | −0.133 | 0.125 | log BB | |
CNS | −1.264 | −2.807 | −1.937 | log PS | ||
Metabolism | substrate | CYP2D6 | No | No | No | |
CYP3A4 | Yes | No | No | |||
inhibitor | CYP1A2 | Yes | No | Yes | ||
CYP2C19 | Yes | No | No | |||
CYP2C9 | Yes | No | No | |||
CYP2D6 | No | No | No | |||
CYP3A4 | No | No | No | |||
Excretion | Total clearance | 0.155 | 1.074 | 0.71 | log mL/min/kg | |
Renal OCT2 substrate | Yes | No | No | |||
Toxicity | AMES toxicity | No | No | No | ||
Max. tolerated dose (human) | 0.143 | −0.361 | 0.931 | log mg/kg/day | ||
inhibitor | hERG I | No | No | No | ||
hERG II | No | No | No | |||
LD50 | 2.54 | 2.592 | 1.833 | mol/kg | ||
LOAEL | 1.024 | 2.062 | 2.535 | log mg/kg_bw/day | ||
Hepatotoxicity | No | No | No | |||
Skin Sensitization | No | No | No | |||
T. Pyriformis toxicity | 2.26 | 0.49 | 0.8 | log mM | ||
Minnow toxicity | 0.033 | 1.667 | 1.168 |
S. No. | Compounds | 2D Structure | Binding Energy (kcal/mol) | Inhibition Constant (µM) |
---|---|---|---|---|
1 | ZINC153731 | | −11.53 | 10.9 |
2 | ZINC69482055 | | −10.67 | 13.32 |
3 | ZINC164387 | | −9.21 | 18.56 |
4 | DFMO * | | −7.25 | 28.85 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
He, S.; Almalki, A.A.; Rafeeq, M.M.; Sain, Z.M.; Alqosaibi, A.I.; Alnamshan, M.M.; Al-Dhuayan, I.S.; Rahaman, A.; Zhang, Y.; Banjer, H.J.; et al. Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of Helicobacter pylori-Associated Gastric Cancer: Structure-Based In Silico Screening of Natural Compounds. Molecules 2022, 27, 732. https://doi.org/10.3390/molecules27030732
He S, Almalki AA, Rafeeq MM, Sain ZM, Alqosaibi AI, Alnamshan MM, Al-Dhuayan IS, Rahaman A, Zhang Y, Banjer HJ, et al. Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of Helicobacter pylori-Associated Gastric Cancer: Structure-Based In Silico Screening of Natural Compounds. Molecules. 2022; 27(3):732. https://doi.org/10.3390/molecules27030732
Chicago/Turabian StyleHe, Shan, Abdulraheem Ali Almalki, Misbahuddin M. Rafeeq, Ziaullah M. Sain, Amany I. Alqosaibi, Mashael M. Alnamshan, Ibtesam S. Al-Dhuayan, Abdul Rahaman, Yang Zhang, Hamsa Jameel Banjer, and et al. 2022. "Targeting Cytotoxin-Associated Antigen A, a Virulent Factor of Helicobacter pylori-Associated Gastric Cancer: Structure-Based In Silico Screening of Natural Compounds" Molecules 27, no. 3: 732. https://doi.org/10.3390/molecules27030732